Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT Cooperation)

American Journal of Cardiology

Volumn 112, Issue 2, 2013, Pages 181-186

  De Luca, Giuseppe ^a,b   Dirksen, Maurits T ^c   Spaulding, Christian ^d   Kelbæk, Henning ^e   Schalij, Martin ^f   Thuesen, Leif ^g   Van Der Hoeven, Bas ^f   Vink, Marteen A ^c   Kaiser, Christoph ^h   Musto, Carmine ⁱ   Chechi, Tania ^j   Spaziani, Gaia ^j   Diaz De La Llera, Luis Salvador ^k   Pasceri, Vincenzo ^l   Di Lorenzo, Emilio ^m   Violini, Roberto ⁱ   Suryapranata, Harry ⁿ   Stone, Gregg W ^o  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e University of Copenhagen   (Denmark)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^j SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l SAN FILIPPO NERI HOSPITAL   (Italy)

^m Division of Cardiology   (Italy)

ⁿ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^o Department of Medicine   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; CYPHER; ENDEAVOR; FIBRINOGEN RECEPTOR ANTAGONIST; RAPAMYCIN; TAXUS(DRUG); UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; CORONARY ARTERY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART REINFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANGIOPLASTY, BALLOON, CORONARY; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879845359     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.03.012     Document Type: Article

References (19)

1. G. De Luca, E. Cassetti, and P. Marino Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction Am J Emerg Med 27 2009 712 719
2. G. De Luca, G. Biondi-Zoccai, and P. Marino Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials Ann Emerg Med 52 2008 665 676
3. G. De Luca, E. Cassetti, M. Verdoia, and P. Marino Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: a meta-analysis of randomised trials Thromb Haemost 102 2009 428 436
4. G. De Luca, E. Navarese, and P. Marino Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials Eur Heart J 30 2009 2705 2713
5. G. De Luca, E.P. Navarese, and H. Suryapranata A meta-analytic overview of thrombectomy during primary angioplasty Int J Cardiol 2012 Jan 28 [Epub ahead of print]
6. D.R. Holmes, H.D. White, K.S. Pieper, S.G. Ellis, R.M. Califf, and E.J. Topol Effects of age on outcome with primary angioplasty versus thrombolysis J Am Coll Cardiol 33 1999 412 419
7. R.J. Golderberg, D. McCormick, J.H. Gurwitz, J. Yarzebski, D. Lessard, and J.M. Gore Age-related trends in short- and long-term survival after myocardial infarction: a 20-year population-based perspective (1975-1995) Am J Cardiol 82 1998 1311 1317
8. V.S. DeGeare, G.W. Stone, L. Grines, B.R. Brodie, D.A. Cox, E. Garcia, T.P. Wharton, J.A. Boura, W.W. O'Neill, and C.L. Grines Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the Primary Angioplasty in Myocardial Infarction Trials) Am J Cardiol 86 2000 30 34
9. G. De Luca, A.W. van 't Hof, J.P. Ottervanger, J.C. Hoorntje, A.T. Gosselink, J.H. Dambrink, M.J. de Boer, and H. Suryapranata Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty Eur Heart J 26 2005 662 666
10. I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, and A. Colombo Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
11. G. De Luca, M.T. Dirksen, C. Spaulding, H. Kelbaek, M. Schalij, L. Thuesen, B. van der Hoeven, M.A. Vink, C. Kaiser, C. Musto, T. Chechi, G. Spaziani, L.S. Díaz de la Llera, V. Pasceri, E. Di Lorenzo, R. Violini, G. Cortese, H. Suryapranata, G.W. Stone Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials Arch Intern Med 172 2012 611 621
12. K. Ataka, D. Chen, and S. Levitsky Effect of aging on intracellular Ca2+, pHi, and contractility during ischemia and reperfusion Circulation 86 Suppl. II 1992 371 376
13. J.P. Headrick Aging impairs functional, metabolic and ionic recovery from ischemia-reperfusion and hypoxia-reoxygenation J Mol Cell Cardiol 30 1998 1415 1430
14. J.D. McCully, T. Tsukube, K. Ataka, I.B. Krukenkamp, H. Feinberg, and S. Levitsky Myocardial cytosolic calcium accumulation during ischemia/reperfusion: the effects of aging and cardioplegia J Card Surg 9 Suppl 1994 449 452
15. G. De Luca, H. Suryapranata, G.W. Stone, D. Antoniucci, G. Biondi-Zoccai, A. Kastrati, M. Chiariello, and P. Marino Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials Int J Cardiol 126 2008 37 44
16. G. Guagliumi, G.W. Stone, D.A. Cox, T. Stuckey, J.E. Tcheng, M. Turco, G. Musumeci, J.J. Griffin, A.J. Lansky, R. Mehran, C.L. Grines, and E. Garcia Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial Circulation 110 2004 1598 1604
17. G. De Luca, H. Suryapranata, J.P. Ottervanger, A.W. van 't Hof, J.C. Hoorntje, J.H. Dambrink, A.T. Gosselink, and M.J. de Boer Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction Int J Cardiol 119 2007 306 309
18. G. De Luca, G.W. Stone, H. Suryapranata, G.J. Laarman, M. Menichelli, C. Kaiser, M. Valgimigli, E. Di Lorenzo, M.T. Dirksen, C. Spaulding, U. Pittl, R. Violini, G. Percoco, and P. Marino Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials Int J Cardiol 133 2009 213 222
19. G. De Luca, H. Suryapranata, G.W. Stone, D. Antoniucci, J.E. Tcheng, F.J. Neumann, F. Van de Werf, E.M. Antman, and E.J. Topol Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765